-+ 0.00%
-+ 0.00%
-+ 0.00%

DexTech operating loss widens to MSEK 1.9 in Q4 FY26; EPS drops to SEK -0.10

PUBT·08/31/2026 09:50:30
Listen to the news
DexTech operating loss widens to MSEK 1.9 in Q4 FY26; EPS drops to SEK -0.10
  • DexTech Medical posted no net sales for April–June 2026, while operating loss widened to MSEK 1.9 from MSEK 1.6.
  • Earnings per share fell to SEK -0.10 from SEK -0.08 in the quarter.
  • For July 2025–June 2026, operating loss widened to MSEK 6.6 from MSEK 5.3; EPS declined to SEK -0.35 from SEK -0.26.
  • Cash and cash equivalents dropped to MSEK 8.6 at June 30, 2026, from MSEK 14.7 a year earlier.
  • Phase I/IIa OsteoDex multiple myeloma study completed; primary safety endpoint met with no significant ODX-related adverse events, follow-up ongoing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexTech Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20260831:BIT:4225:0) on August 31, 2026, and is solely responsible for the information contained therein.